This project is designed to use NMR to follow the progressive development of hepatocellular carcinoma in the rat following treatment with chemical carcinogens. Using a modified Toronto (Solt-Farber) protocol, one may treat animals over an initial two-week period and follow the appearance of progressively more agressive cell populations (nodules), hepatocellular carcinoma, and eventually metastatic carcinoma at 10 to 16 months. Six to eight weeks after the initiation of treatment, there are 50-150 nodules ranging in size from 0.1 to 3 mm. Most of these regress so that by 4-5 months, only a few (3-8) nodules persist. Eventually these give rise to carcinoma. We will use a Biospec 310/2.3 imaging system to study this process. We will first image isolated nodules to develop appropriate imaging parameters (time, slice thickness, repetition times, etc.). We will then apply this information to imaging in vivo. Specifically, we will test the hypothesis that most hepatocellular carcinomas rise in persistent nodules by periodic imaging of these nodules in vivo. We will correlate imaging parameters (e.g., relaxation times) with biological phenomena including in situ hybridization for oncogene expression and the biological behavior of excised transplanted nodules or cell lines made from them. We will also image metastases found in these animals. To extend the generality of our findings we will employ the carcinogen/phenobarbital protocol for tumor induction on a comparative basis with the modified Toronto protocol.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA041078-02
Application #
3820790
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Lee, Seung-Cheol; Arias-Mendoza, Fernando; Poptani, Harish et al. (2012) Prediction and Early Detection of Response by NMR Spectroscopy and Imaging. PET Clin 7:119-26
Hultman, Kristi L; Raffo, Anthony J; Grzenda, Adrienne L et al. (2008) Magnetic resonance imaging of major histocompatibility class II expression in the renal medulla using immunotargeted superparamagnetic iron oxide nanoparticles. ACS Nano 2:477-84
Stoyanova, Radka; Querec, Troy D; Brown, Truman R et al. (2004) Normalization of single-channel DNA array data by principal component analysis. Bioinformatics 20:1772-84
Stoyanova, Radka; Nicholls, Andrew W; Nicholson, Jeremy K et al. (2004) Automatic alignment of individual peaks in large high-resolution spectral data sets. J Magn Reson 170:329-35
Stoyanova, Radka; Nicholson, Jeremy K; Lindon, John C et al. (2004) Sample classification based on Bayesian spectral decomposition of metabonomic NMR data sets. Anal Chem 76:3666-74
Sajda, Paul; Du, Shuyan; Brown, Truman R et al. (2004) Nonnegative matrix factorization for rapid recovery of constituent spectra in magnetic resonance chemical shift imaging of the brain. IEEE Trans Med Imaging 23:1453-65
Nahum, Alan E; Movsas, Benjamin; Horwitz, Eric M et al. (2003) Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio. Int J Radiat Oncol Biol Phys 57:391-401
Stoyanova, R; Brown, T R (2002) NMR spectral quantitation by principal component analysis. III. A generalized procedure for determination of lineshape variations. J Magn Reson 154:163-75
Stoyanova, R; Brown, T R (2001) NMR spectral quantitation by principal component analysis. NMR Biomed 14:271-7
Ochs, M F; Stoyanova, R S; Arias-Mendoza, F et al. (1999) A new method for spectral decomposition using a bilinear Bayesian approach. J Magn Reson 137:161-76

Showing the most recent 10 out of 46 publications